Biobanking in the COVID-19 Era and Beyond: Part 1 How Early Experiences Can Translate into Actionable Wisdom #MMPMID33164554
Allocca CM; Bledsoe MJ; Albert M; Anisimov SV; Bravo E; Castelhano MG; Cohen Y; De Wilde M; Furuta K; Kozlakidis Z; Martin D; Martins A; McCall S; Morrin H; Pugh RS; Schacter B; Simeon-Dubach D; Snapes E
Biopreserv Biobank 2020[Dec]; 18 (6): 533-546 PMID33164554show ga
The era of COVID-19 has brought about a number of novel challenges for the global biobanking community. To better position the biobanking community to cope with current and future challenges, the International Society for Biological and Environmental Repositories (ISBER) COVID-19 Response Task Force was convened to identify needs and gaps in biobanking tools (existing resources that support good practice), for example, standards, best practices, business, etc. and to make recommendations to benefit the community. Toward these goals, the Task Force assembled a set of questions to explore individual biobanks' experiences, with emphasis on identification of key challenges and approaches, including tools employed. A survey was designed with the use of these questions and administered by ISBER. This article presents a summary of the aggregated data obtained from the survey responses, illustrating some of the major issues encountered and identifying which tools the survey respondents found most useful. In particular, this article focuses on the challenges identified during the early months of the COVID-19 era. Recommendations are provided to support biobank emergency preparedness for the future, address lessons learned, and propose solutions to bridge identified gaps. The analysis and the complete survey dataset will also inform the larger Task Force goal to develop specific tool recommendations.
Biopreserv+Biobank 2020 ; 18 (6): 533-546
